Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Myovant Sciences aggregated by PharmaCompass.com.

    Client Virtual Booth

    MYOVANT SCIENCES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Myovant Sciences
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2000 Sierra Point Parkway, 9th Floor Brisbane, CA 94005
    Telephone
    Telephone
    650-392-0222
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.myovant.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/myovant-sciences/
    Twitter
    Twitter
    https://twitter.com/myovant?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Myovant endometriosis survey shows crippling effect on women
    Myovant endometriosis survey shows crippling effect on women

    https://www.fiercepharma.com/marketing/myovant-endometriosis-survey-shows-women-consider-quitting-work-school-due-symptoms

    Jacqueline Renfrow FIERCE PHARMA
    19 May 2023
    Share Share
    Sumitomo Pharma tidies up 7 units into 1 combined U.S. entity
    Sumitomo Pharma tidies up 7 units into 1 combined U.S. entity

    https://www.fiercebiotech.com/biotech/sumitomo-pharma-tidies-7-units-one-combined-us-entity-spring-cleaning

    Annalee Armstrong FIERCE BIOTECH
    03 Apr 2023
    Share Share
    Sumitovant Biopharma Acquires Myovant Sciences in $1.7B Deal
    Sumitovant Biopharma Acquires Myovant Sciences in $1.7B Deal

    https://www.contractpharma.com/contents/view_breaking-news/2023-03-10/sumitovant-biopharma-acquires-myovant-sciences-in-17b-deal/?widget=listSection

    CONTRACT PHARMA
    10 Mar 2023
    Share Share
    Myovant Announces Updates and Financial Results for Third Fiscal Quarter 2022
    Myovant Announces Updates and Financial Results for Third Fiscal Quarter 2022

    https://www.globenewswire.com/news-release/2023/01/26/2596463/0/en/Myovant-Sciences-Announces-Corporate-Updates-and-Financial-Results-for-Third-Fiscal-Quarter-2022.html

    GLOBENEWSWIRE
    26 Jan 2023
    Share Share
    Myovant Sciences Investor Alert by the Former Attorney General of Louisiana
    Myovant Sciences Investor Alert by the Former Attorney General of Louisiana

    https://www.businesswire.com/news/home/20230125005713/en

    BUSINESSWIRE
    25 Jan 2023
    Share Share
    Myovant, Pfizer debut first branded campaign for prostate cancer med Orgovyx
    Myovant, Pfizer debut first branded campaign for prostate cancer med Orgovyx

    https://endpts.com/myovant-pfizer-debut-first-branded-campaign-for-prostate-cancer-med-orgovyx/

    Beth Snyder Bulik ENDPTS
    13 Jan 2023
    Share Share
    Myovant Sciences Announces Corporate Updates and Financial Results for Q2 2022
    Myovant Sciences Announces Corporate Updates and Financial Results for Q2 2022

    https://www.globenewswire.com/news-release/2022/10/26/2541832/0/en/Myovant-Sciences-Announces-Corporate-Updates-and-Financial-Results-for-Second-Fiscal-Quarter-2022.html

    GLOBENEWSWIRE
    26 Oct 2022
    Share Share
    Weeks after Rejecting First Offer, Myovant Agrees to Acquisition by Sumitovant
    Weeks after Rejecting First Offer, Myovant Agrees to Acquisition by Sumitovant

    https://www.biospace.com/article/weeks-after-rejecting-first-offer-myovant-agrees-to-acquisition-by-sumitovant/

    Alex Keown BIOSPACE
    25 Oct 2022
    Share Share
    Myovant Sciences Cancels Second Quarter Earnings Conference Call
    Myovant Sciences Cancels Second Quarter Earnings Conference Call

    https://www.globenewswire.com/news-release/2022/10/24/2540378/0/en/Myovant-Sciences-Cancels-Second-Quarter-Earnings-Conference-Call.html

    GLOBENEWSWIRE
    24 Oct 2022
    Share Share
    Myovant Announces New Employment Inducement Grants Under NYSE Rule 303A.08
    Myovant Announces New Employment Inducement Grants Under NYSE Rule 303A.08

    https://www.globenewswire.com/news-release/2022/10/18/2536936/0/en/Myovant-Sciences-Announces-New-Employment-Inducement-Grants-Under-NYSE-Rule-303A-08.html

    GLOBENEWSWIRE
    18 Oct 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search